Premier League
Folarin Balogun Withdraws from Everton Transfer Over Medical Dispute, Monaco CEO Confirms
Folarin Balogun’s £40m transfer to Everton fell through after he withdrew over medical handling concerns, Monaco CEO Thiago Scuro revealed, leaving Everton without their targeted forward reinforcement.

Folarin Balogun has withdrawn from a £40 million transfer to Everton following a dispute over the handling of his medical examination, Monaco’s chief executive Thiago Scuro has confirmed. Despite a deal sheet being signed just before the transfer deadline, the US international forward ultimately rejected the move.
The transfer was intended to strengthen Everton’s attacking options ahead of the Premier League season. However, after an issue arose during Balogun’s medical, Everton renegotiated the payment structure with Monaco. Shortly after signing the deal sheet around 11pm on deadline day, Balogun pulled out of the transfer, citing concerns about how his medical was managed.
This sudden withdrawal left Everton scrambling to find alternative forward reinforcements. The club’s attempts to secure forwards Joshua Zirkzee and Tammy Abraham on loan were unsuccessful, compounding their challenges in the transfer window and limiting their options to boost the frontline.
Monaco’s CEO Thiago Scuro also addressed the club’s decision not to sell midfielder Lamine Camara to Chelsea late on deadline day, emphasizing Monaco’s commitment to retaining key players. Scuro’s comments suggest the club prioritized squad stability amid the late transfer activity.
The collapse of Balogun’s transfer has immediate implications for Everton’s squad depth and attacking options as the season progresses. The club must now rely on their existing forwards or pursue other transfer opportunities to strengthen their frontline. For Monaco, retaining Balogun ensures they maintain a competitive squad in Ligue 1 and European competitions.
Looking ahead, Everton will need to adapt quickly to the absence of their targeted signing, while Monaco will focus on reintegrating Balogun into their plans following the failed move. The transfer saga highlights the complexities and uncertainties that can arise in deadline-day negotiations, particularly concerning medical assessments and player approval.
For further details, see the original report by The Guardian: here.



